Effect of pulse pressure on vascular smooth muscle cell migration: the role of urokinase and matrix metalloproteinase

Thromb Haemost. 1999 Feb;81(2):293-300.

Abstract

Plasminogen activator (PA) expression plays an important role in smooth muscle cell (SMC) migration and may therefore contribute to mechanical force-induced arterialization of vein grafts. The aim of this study was to determine whether pulse pressure due to pulsatile flow modulates SMC migration via urokinase (u-PA)-dependent mechanisms. Using a perfused transcapillary culture system, human umbilical vein SMC were exposed to pulse pressures (0-56 mmHg), in the absence or presence of human umbilical vein endothelial cells (EC) by varying pulsatile flow rates (0 ml/min to 25 ml/min). SMC cultured in the absence of EC increased their migration following exposure to increased pulse pressure (248+/-14%). Both u-PA and matrix metallo-proteinase 1 (MMP-1) expression was significantly elevated in SMC exposed to pressure as compared to static controls. The role of proteases in the pulse pressure-induced enhancement of SMC migration was confirmed following pretreatment with aprotinin, an anti u-PA antibody and metalloproteinase inhibitors (181+/-14% for aprotinin vs. 256+/-25% for control, 108+/-4% for anti-u-PA antibody vs. 233+/-17% for non-immune IgG, and 114+/-9% for BB-94, 105+/-7% for BB-3103 vs. 222+/-5% for control). Using SMC derived from u-PA gene knock-out mice, the SMC migratory response to increased pulse pressure was completely inhibited despite a significant increase in MMP expression in these cells. These results suggest that pulse pressure due to pulsatile flow induces SMC migration in vitro via u-PA and MMP-dependent mechanisms. Moreover, u-PA gene deletion results in blunting of pressure-induced SMC migration despite the endogenous upregulation of metalloproteinase. Modulation of u-PA expression by pressure may thus represent an important mechanism whereby hemodynamic forces regulate smooth muscle cell migration.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Aprotinin / pharmacology
  • Blood Pressure*
  • Cell Communication*
  • Cells, Cultured
  • Coculture Techniques
  • Collagenases / biosynthesis
  • Collagenases / deficiency
  • Collagenases / genetics
  • Collagenases / physiology
  • Endothelium, Vascular / cytology*
  • Enzyme Inhibitors / pharmacology
  • Hemorheology*
  • Humans
  • Hydroxamic Acids / pharmacology
  • Hyperplasia
  • Matrix Metalloproteinase 13
  • Metalloendopeptidases / antagonists & inhibitors
  • Metalloendopeptidases / physiology*
  • Mice
  • Mice, Knockout
  • Muscle, Smooth, Vascular / cytology*
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / enzymology
  • Phenylalanine / analogs & derivatives
  • Phenylalanine / pharmacology
  • Pulse
  • RNA, Messenger / biosynthesis
  • Stress, Mechanical
  • Thiophenes / pharmacology
  • Tunica Intima / pathology
  • Umbilical Veins
  • Urokinase-Type Plasminogen Activator / antagonists & inhibitors
  • Urokinase-Type Plasminogen Activator / genetics
  • Urokinase-Type Plasminogen Activator / physiology*

Substances

  • BB 3103
  • Enzyme Inhibitors
  • Hydroxamic Acids
  • RNA, Messenger
  • Thiophenes
  • Phenylalanine
  • Aprotinin
  • batimastat
  • Urokinase-Type Plasminogen Activator
  • Collagenases
  • MMP13 protein, human
  • Matrix Metalloproteinase 13
  • Metalloendopeptidases
  • Mmp13 protein, mouse